35624-81-8

Upstream product

• 5510-31-6 2,3-dihydro-spiro[benzo[e][1,2]thiazine-4,2'-[1,3]dioxolane] 1,1-dioxide 
• 100-39-0 benzyl bromide 
• 81-07-2 saccharin 
• 5510-09-8 1,1-dioxo-2,3-dihydro-1H-1λ⁶-benzo[e][1,2]thiazin-4-one 
• 40506-05-6 1,1-dioxo-2-(2-oxo-propyl)-1,2-dihydro-1λ⁶-benzo[d]isothiazol-3-one 

Downstream Products

• 35511-16-1 2-benzyl-1,1-dioxo-2,3-dihydro-1H-1λ⁶-benzo[e][1,2]thiazin-4-one 
• 35510-99-7 2-benzyl-1,1,4-trioxo-1,2,3,4-tetrahydro-1λ⁶-benzo[e][1,2]thiazine-3-carboxylic acid anilide 
• 35511-01-4 1,1,4-trioxo-1,2,3,4-tetrahydro-1λ⁶-benzo[e][1,2]thiazine-3-carboxylic acid anilide 

Relevant academic research and scientific papers

Synthesis and in vitro evaluation of novel small molecule inhibitors of bacterial arylamine N-acetyltransferases (NATs)

The synthesis and inhibitory activity of a series of 5-substituted-(1,1-dioxo-2,3-dihydro-1H-1λ6-benzo[e] [1,2]thiazin-4-ylidene)-thiazolidine-2,4-dione derivatives as competitive inhibitors of recombinant bacterial arylamine-N-acetyltransferas